Ning Pan P - OmicsDI

Show results for

Unknown (163)
Proteomics (13)
Metabolomics (6)
Transcriptomics (4)

Organisms

Homo sapiens (11)
Mus musculus (2)
Tardigrada (2)
Escherichia coli (1)
Fusarium cf. oxysporum (1)
Oryza sativa (1)

Repository

iProX (7)
MetaboLights (6)
pride (6)
biostudies-arrayexpress (4)

Tissue

Cell culture (1)
Epithelial cell (1)
Leaf (1)
Mammary gland (1)
Mammary gland tumor cell (1)
Mycelium (1)
Plant cell (1)
Skin (1)

Disease

Breast cancer (1)

Technology Type

Mass Spectrometry (6)
Shotgun proteomics (4)
Mass spectrometry (3)
Mass spectrometry assay (3)
Gel-based experiment (1)
SWATH MS (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
TBS380 (1)
Nanodrop2000 (1)
NA (1)
Illumina NovaSeq 6000 (1)
Gas Chromatography MS - - - Liquid Chromatography MS - - - Gas Chromatography MS - positive (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2024 (5)
2023 (4)
2026 (4)
2025 (3)
2022 (3)
2016 (1)
2014 (1)
2006 (1)
2020 (1)

CHEBI ID

CHEBI:10037 (1)
CHEBI:10072 (1)
CHEBI:116314 (1)
CHEBI:12962 (1)
CHEBI:131429 (1)
CHEBI:131887 (1)
CHEBI:132541 (1)
CHEBI:132542 (1)
CHEBI:132543 (1)
CHEBI:132558 (1)
CHEBI:132586 (1)
CHEBI:132588 (1)
CHEBI:132590 (1)
CHEBI:132628 (1)
CHEBI:132983 (1)
CHEBI:134028 (1)
CHEBI:134287 (1)
CHEBI:136141 (1)
CHEBI:137259 (1)
CHEBI:138560 (1)
CHEBI:139325 (1)
CHEBI:140960 (1)
CHEBI:140964 (1)
CHEBI:142219 (1)
CHEBI:142440 (1)
CHEBI:14336 (1)
CHEBI:143762 (1)
CHEBI:145255 (1)
CHEBI:145571 (1)
CHEBI:145828 (1)

Metabolite Name

(+)-WIN 55,212-2 (1)
(+/-)-C75 (1)
(+/-)-Gingerol (1)
(+/-)12(13)-DiHOME (1)
(+/-)12-HpETE (1)
(+/-)13-HODE (1)
(+/-)18-HEPE (1)
(+/-)19(20)-DiHDPA (1)
(+/-)8(9)-DiHET (1)
(+/-)9,10-dihydroxy-12Z-octadecenoic acid (1)
(-)-Camphanic acid (1)
(15Z)-9,12,13-Trihydroxy-15-octadecenoic acid (1)
(1S,6R,11aR,13R,14aS)-1,13-dihydroxy-6-methyl-1H,4H,6H,7H,8H,9H,11aH,12H,13H,14H,14aH-cyclopenta[f]oxacyclotridecan-4-one (1)
(2E)-3-(4-Acetoxy-2,3-dihydroxy-2,5,5,8a-tetramethyldecahydro-1-naphthalenyl)acrylic acid (1)
(2E)-3-(Acetoxymethyl)-5-[(1S,4aR,8aR)-2-(hydroxymethyl)-5,5,8a-trimethyl-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenyl]-2-pentenoic acid (1)
(2E)-5-[(8aS)-2,5,5,8a-tetramethyl-3-oxo-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-methylpent-2-enoic acid (1)
(2E,4E)-N-(2-methylpropyl)dodeca-2,4-dienamide (1)
(2R)-2,3-Dihydroxypropanoic acid (1)
(2S)-N-[(2S)-1-Amino-3-cyclohexyl-1-oxo-2-propanyl]-1-(cyclohexylcarbonyl)-4-[4-(dimethylamino)benzoyl]-2-piperazinecarboxamide (1)
(2S,3R,4S,5S,6R)-2-{[(2S)-2-[(2R,5S,8S,10R,11R,14S,15R,16R)-8-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5,16-dihydroxy-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0??,?¡?0?a?a,?a??]heptadecan-14-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol (1)
(2S,3S)-8-[(2R,3S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-3-yl]-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one (1)
(2S,5aS,8aR)-1-Methyl-6-(4-methylbenzyl)-2-[3-(4-morpholinyl)-3-oxopropyl]octahydropyrrolo[3,2-E][1,4]diazepin-5(2H)-one (1)
(2S,5aS,8aR)-6-(4-Methoxybenzyl)-1-methyl-2-[3-(4-morpholinyl)-3-oxopropyl]octahydropyrrolo[3,2-E][1,4]diazepin-5(2H)-one (1)
(2Z)-2-Octyl-2-pentenedioic acid (1)
(2Z)-5-(1,2,4a,5-tetramethyl-7-oxo-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl)-3-methylpent-2-enoic acid (1)
(3E,6R)-6-hydroxy-6-[(1R,2R,4S,10S,11S,13R,15R)-13-hydroxy-1,6,6,11,15-pentamethyl-5,17-dioxo-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0??,?¡?0?a?a,?a??]heptadec-7-en-14-yl]-2-methyl-5-oxohept-3-en-2-yl acetate (1)
(3R,5S)-1-(1H-Imidazol-2-ylmethyl)-5-[3-(3-nitrophenyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinol (1)
(3R,5S)-1-Isopropyl-5-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinol (1)
(3beta,5xi,6alpha,9xi,12beta)-20-(beta-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl beta-D-glucopyranoside (1)
(3beta,8xi,9xi,12beta,14beta)-11,12,14-Trihydroxy-20-oxopregn-5-en-3-yl 6-deoxyhexopyranosyl-(1-4)-2,6-dideoxy-3-O-methylhexopyranosyl-(1-4)-2,6-dideoxy-3-O-methylhexopyranoside (1)

Study type

Transcription profiling by array (3)
RNA-seq of coding RNA (1)

Release Date

2025 (31)
2024 (24)
2022 (22)
2023 (18)
2021 (18)
2020 (12)
2019 (10)
2016 (6)
2014 (5)
2018 (5)
2015 (4)
2026 (3)
2017 (3)
2013 (3)
2012 (2)
2006 (1)

Lab affiliation

College of Biology, Hunan University (1)
Dermatology and Venereology Division, Department of Medicine (Solna), Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden (1)
Division of Molecular Pathology Molecular and Systems Oncology Team The Institute of Cancer Research 237 Fulham Road, SW3 6JB London United Kingdom (1)
Qingdao Agriculture University (1)
Shandong University (1)
Shengjing hospital of China Medical University (1)

Previous page
1 / 19
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 19
Next page

Sort by:

Relevance

Page size

Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis.

Not available

S-EPMC6137246 | biostudies-literature

Quantitative acetylome analysis of Fusarium oxysporum

Quantitative proteome and acetylome analyses were conducted by comparing the acetylation levels of the SM to those of the NM. The collected cellular proteins were extracted, digested, and labeled by different TMTs. For acetylation profiling, the pan acetyl-lysine antibody was employed to enrich the ...

ORGANISM(S): Fusarium cf. oxysporum

2022-06-09 | PXD029583 | Pride